Linagliptin for patients aged 70 years or older with type 2 diabetes inadequately controlled with common antidiabetes treatments: a randomised, double-blind, placebo-controlled trial
Barnett, Anthony H, Prof, Huisman, Holger, MSc, Jones, Russell, MSc, von Eynatten, Maximilian, MD, Patel, Sanjay, MB ChB, Woerle, Hans-Juergen, MD
Published in The Lancet (British edition) (26.10.2013)
Published in The Lancet (British edition) (26.10.2013)
Get full text
Journal Article
Consistent effects of empagliflozin on cardiovascular and kidney outcomes irrespective of diabetic kidney disease categories: Insights from the EMPA‐REG OUTCOME trial
Wanner, Christoph, Inzucchi, Silvio E., Zinman, Bernard, Koitka‐Weber, Audrey, Mattheus, Michaela, George, Jyothis T., Eynatten, Maximilian, Hauske, Sibylle J.
Published in Diabetes, obesity & metabolism (01.12.2020)
Published in Diabetes, obesity & metabolism (01.12.2020)
Get full text
Journal Article
Kidney Disease End Points in a Pooled Analysis of Individual Patient–Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes
Cooper, Mark E., MBBS, PhD, Perkovic, Vlado, MBBS, PhD, McGill, Janet B., MD, Groop, Per-Henrik, MD, DMSC, Wanner, Christoph, MD, Rosenstock, Julio, MD, Hehnke, Uwe, MSc, Woerle, Hans-Juergen, MD, von Eynatten, Maximilian, MD
Published in American journal of kidney diseases (01.09.2015)
Published in American journal of kidney diseases (01.09.2015)
Get full text
Journal Article
Empagliflozin and kidney outcomes in Asian patients with type 2 diabetes and established cardiovascular disease: Results from the EMPA‐REG OUTCOME® trial
Kadowaki, Takashi, Nangaku, Masaomi, Hantel, Stefan, Okamura, Tomoo, Eynatten, Maximilian, Wanner, Christoph, Koitka‐Weber, Audrey
Published in Journal of diabetes investigation (01.05.2019)
Published in Journal of diabetes investigation (01.05.2019)
Get full text
Journal Article
Linagliptin and cardiorenal outcomes in Asians with type 2 diabetes mellitus and established cardiovascular and/or kidney disease: subgroup analysis of the randomized CARMELINA® trial
Inagaki, Nobuya, Yang, Wenying, Watada, Hirotaka, Ji, Linong, Schnaidt, Sven, Pfarr, Egon, Okamura, Tomoo, Johansen, Odd Erik, George, Jyothis T., von Eynatten, Maximilian, Rosenstock, Julio, Perkovic, Vlado, Wanner, Christoph, Cooper, Mark E., Alexander, John H., Komuro, Issei, Nangaku, Masaomi
Published in Diabetology international (01.04.2020)
Published in Diabetology international (01.04.2020)
Get full text
Journal Article
Association of Lipopolysaccharide-Binding Protein and Coronary Artery Disease in Men
Lepper, Philipp M., MD, Schumann, Christian, MD, Triantafilou, Kathy, PhD, Rasche, F. Maximilian, MD, Schuster, Tibor, MS, Frank, Hedwig, Schneider, E. Marion, PhD, Triantafilou, Martha, PhD, von Eynatten, Maximilian, MD
Published in Journal of the American College of Cardiology (03.07.2007)
Published in Journal of the American College of Cardiology (03.07.2007)
Get full text
Journal Article
Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial
Ma, Ronald CW, Del Prato, Stefano, Gallwitz, Baptist, Shivane, Vyankatesh K, Lewis‐D'Agostino, Diane, Bailes, Zelie, Patel, Sanjay, Lee, Jisoo, Eynatten, Maximilian, Di Domenico, Maximiliano, Ross, Stuart A
Published in Journal of diabetes investigation (01.05.2018)
Published in Journal of diabetes investigation (01.05.2018)
Get full text
Journal Article
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, Christoph, Inzucchi, Silvio E, Lachin, John M, Fitchett, David, von Eynatten, Maximilian, Mattheus, Michaela, Johansen, Odd Erik, Woerle, Hans J, Broedl, Uli C, Zinman, Bernard
Published in The New England journal of medicine (28.07.2016)
Published in The New England journal of medicine (28.07.2016)
Get full text
Journal Article
S282 Real-World Use of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) in Adults With Recurrent Clostridioides difficile Infection in the United States
Akerman, Stuart, Gumaste, Ashish, Chen, Michael, Connor, Lisa, von Eynatten, Maximilian, De Vries, Jane, Nguyen, Dianne
Published in The American journal of gastroenterology (01.10.2024)
Published in The American journal of gastroenterology (01.10.2024)
Get full text
Journal Article
Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease: A 10-year Prospective Study
Eynatten, Maximilian von, Breitling, Lutz P, Roos, Marcel, Baumann, Marcus, Rothenbacher, Dietrich, Brenner, Hermann
Published in Arteriosclerosis, thrombosis, and vascular biology (01.09.2012)
Published in Arteriosclerosis, thrombosis, and vascular biology (01.09.2012)
Get full text
Journal Article
Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA‐T2D trial
Groop, Per‐Henrik, Cooper, Mark E., Perkovic, Vlado, Hocher, Berthold, Kanasaki, Keizo, Haneda, Masakazu, Schernthaner, Guntram, Sharma, Kumar, Stanton, Robert C., Toto, Robert, Cescutti, Jessica, Gordat, Maud, Meinicke, Thomas, Koitka‐Weber, Audrey, Thiemann, Sandra, von Eynatten, Maximilian
Published in Diabetes, obesity & metabolism (01.11.2017)
Published in Diabetes, obesity & metabolism (01.11.2017)
Get full text
Journal Article
2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial
Gallwitz, Baptist, Prof, Rosenstock, Julio, MD, Rauch, Thomas, MD PhD, Bhattacharya, Sudipta, MSJ, Patel, Sanjay, MB ChB, von Eynatten, Maximilian, MD, Dugi, Klaus A, MD, Woerle, Hans-Juergen, MD
Published in The Lancet (British edition) (04.08.2012)
Published in The Lancet (British edition) (04.08.2012)
Get full text
Journal Article
Blood glucose, diabetes and metabolic control in patients with community-acquired pneumonia
Lepper, Philipp M., Bals, Robert, Jüni, Peter, von Eynatten, Maximilian
Published in Diabetologia (01.11.2020)
Published in Diabetologia (01.11.2020)
Get full text
Journal Article
Empagliflozin Induces Transient Diuresis Without Changing Long-Term Overall Fluid Balance in Japanese Patients With Type 2 Diabetes
Yasui, Atsutaka, Lee, Ganghyuck, Hirase, Tetsuaki, Kaneko, Tatsuroh, Kaspers, Stefan, von Eynatten, Maximilian, Okamura, Tomoo
Published in Diabetes therapy (01.04.2018)
Published in Diabetes therapy (01.04.2018)
Get full text
Journal Article
Urinary Proteomics as a Tool to Identify Kidney Responders to Dipeptidyl Peptidase‐4 Inhibition: A Hypothesis‐Generating Analysis from the MARLINA‐T2D Trial
Siwy, Justyna, Klein, Thomas, Rosler, Marcel, Eynatten, Maximilian
Published in Proteomics. Clinical applications (01.03.2019)
Published in Proteomics. Clinical applications (01.03.2019)
Get full text
Journal Article
Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth With Type 2 Diabetes
Bjornstad, Petter, Laffel, Lori, Tamborlane, William V, Simons, Gudrun, Hantel, Stefan, von Eynatten, Maximilian, George, Jyothis, Marquard, Jan, Cherney, David Z I
Published in Diabetes care (01.08.2018)
Published in Diabetes care (01.08.2018)
Get full text
Journal Article
Cardiovascular safety with linagliptin in patients with type 2 diabetes mellitus: a pre-specified, prospective, and adjudicated meta-analysis of a phase 3 programme
Johansen, Odd Erik, Neubacher, Dietmar, von Eynatten, Maximilian, Patel, Sanjay, Woerle, Hans-Juergen
Published in Cardiovascular diabetology (10.01.2012)
Published in Cardiovascular diabetology (10.01.2012)
Get full text
Journal Article
Urinary dipeptidyl peptidase‐4 protein is increased by linagliptin and is a potential predictive marker of urine albumin‐to‐creatinine ratio reduction in patients with type 2 diabetes
Klein, Thomas, Tammen, Harald, Mark, Michael, Benetti, Elisa, Delić, Denis, Schepers, Cornelia, Eynatten, Maximilian
Published in Diabetes, obesity & metabolism (01.08.2021)
Published in Diabetes, obesity & metabolism (01.08.2021)
Get full text
Journal Article
Efficacy and safety of linagliptin to improve glucose control in older people with type 2 diabetes on stable insulin therapy: A randomized trial
Ledesma, Gilbert, Umpierrez, Guillermo E., Morley, John E., Lewis‐D'Agostino, Diane, Keller, Annett, Meinicke, Thomas, Walt, Sandra, von Eynatten, Maximilian
Published in Diabetes, obesity & metabolism (01.11.2019)
Published in Diabetes, obesity & metabolism (01.11.2019)
Get full text
Journal Article
A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes
Jax, Thomas, Stirban, Alin, Terjung, Arne, Esmaeili, Habib, Berk, Andreas, Thiemann, Sandra, Chilton, Robert, von Eynatten, Maximilian, Marx, Nikolaus
Published in Cardiovascular diabetology (21.01.2017)
Published in Cardiovascular diabetology (21.01.2017)
Get full text
Journal Article